Innovotech Inc. (IOT.V)

0.1650 0.0000 (0.00%) At close: 02:48PM EDT

Innovotech Inc.

2011-94 Street
Suite L131
Edmonton, AB T6N 1H1
Canada

https://www.innovotech.ca

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. James Timourian Ph.D.	Chairman, CEO, Pres & Sec.	13.5k	N/A	N/A
Mr. Alan C. Savage	CFO & Director	N/A	4.25k	1943
Dr. Tyler Boone	Chief Operating Officer	N/A	N/A	N/A
Dr. Patricia Nadworny	Chief Scientific Officer and Quality & Safety Director	N/A	N/A	N/A
Dr. Merle Olson	Scientific Consultant	N/A	N/A	N/A

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States, and internationally. The company offers InnovoSIL, an antimicrobial agents for coating onto or incorporation into medical devices; MBEC Assay, a screening assay used to determine the efficacy of antimicrobials against biofilms of various microorganisms; and AgreGuard, an antimicrobial for crop protection. It also provides implant medical devices; antibiotic, antimicrobial, and biocide resistance; biofilm eradication surface and MBEC Assay testing; and analytical services. The company serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food safety, transportation, and healthcare. Innovotech Inc. was incorporated in 2001 is headquartered in Edmonton, Canada.

Corporate Governance

Innovotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.